Skip to content Skip to footer

Research Portal of the TU Dresden

JAMA Oncology

ISSNs: 2374-2437

Additional searchable ISSN (electronic): 2374-2445

American Medical Association

Scopus rating (2022): CiteScore 44.3 SJR 8.103 SNIP 6.653

Journal

Titles	JAMA Oncology JAMA oncology
Additional searchable titles	JAMA oncology
ISSNs	2374-2437
Additional searchable ISSN (electronic)	2374-2445
Publisher	American Medical Association
ZDB-ID	2810928-4

Keywords

ASJC Scopus subject areas

Oncology
Cancer Research

Library keywords

610 Medicine and health

Related content

Research output

Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial

Bornhäuser, M., Schliemann, C., Schetelig, J., Röllig, C., Kramer, M., Glass, B., Platzbecker, U., & 22 othersBurchert, A., Hänel, M., Müller, L. P., Klein, S., Bug, G., Beelen, D., Rösler, W., Schäfer-Eckart, K., Schmid, C., Jost, E., Lenz, G., Tischer, J., Spiekermann, K., Pfirrmann, M., Serve, H., Stölzel, F., Alakel, N., Middeke, J. M., Thiede, C., Ehninger, G., Berdel, W. E. & Stelljes, M., 1 Apr 2023, In: JAMA oncology. 9, 4, p. 519-526 8 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination with Extension of Survival among Patients with Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial

DCVax study group & Krex, D., 19 Jan 2023, In: JAMA oncology. 9, 1, p. 112-121 10 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial

The GBG and AGO-B, Jul 2022, In: JAMA oncology. 8, 7, p. 1010-1018 9 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status

PETACC-8 study investigators, 12 Jul 2018, In: JAMA oncology. 4, 7, p. e173695

Research output: Contribution to journal › Research article › Contributed › peer-review

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials

Zaanan, A., Shi, Q., Taieb, J., Alberts, S. R., Meyers, J. P., Smyrk, T. C., Julie, C., & 10 othersZawadi, A., Tabernero, J., Mini, E., Goldberg, R. M., Folprecht, G., Van Laethem, J. L., Le Malicot, K., Sargent, D. J., Laurent-Puig, P. & Sinicrope, F. A., 1 Mar 2018, In: JAMA oncology. 4, 3, p. 379-383 5 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (6)